The global stem cell patent landscape: implications for efficient technology transfer and commercial development

被引：57

作者：

Bergman, Karl ^{[1
]}

Graff, Gregory D.

机构：

[1] Chalmers Univ Technol, Goteborg Int Biosci Business Sch, S-41296 Gothenburg, Sweden

[2] Univ Calif Davis, Davis, CA 95616 USA

[3] Chalmers Univ Technol, Ctr Intellectual Property Studies, S-41296 Gothenburg, Sweden

[4] Univ Gothenburg, Gothenburg, Sweden

来源：

NATURE BIOTECHNOLOGY | 2007年 / 25卷 / 04期

关键词：

D O I：

10.1038/nbt0407-419

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Characteristics of the complex and growing stem cell patent landscape indicate strategies by which public sector research institutions could improve the efficiency of intellectual property agreements and technology transfers in stem cells.

引用

页码：419 / 424

页数：6

共 27 条

[11] Can patents deter innovation? The anticommons in biomedical research [J].

Heller, MA ;

Eisenberg, RS .

SCIENCE, 1998, 280 (5364) :698-701

[12] Nuclear reprogramming and pluripotency [J].

Hochedlinger, Konrad ;

Jaenisch, Rudolf .

NATURE, 2006, 441 (7097) :1061-1067

[13]

Jaffe A., 2004, Innovation and its discontents: How our broken patent system is endangering innovation and progress, and what to do about it

[14] Science and law - Intellectual property and human embryonic stem cell research [J].

Loring, JF ;

Campbell, C .

SCIENCE, 2006, 311 (5768) :1716-1717

[15] Contracting into liability rules: Intellectual property rights and collective rights organizations [J].

Merges, RP .

CALIFORNIA LAW REVIEW, 1996, 84 (05) :1293-1393

[16]

OCONNOR SM, 2005, NEW ENG L REV, V39, P665

[17] The gatekeepers of hES cell products [J].

Rabin, S .

NATURE BIOTECHNOLOGY, 2005, 23 (07) :817-819

[18]

RAI AK, 2003, LAW CONTEMP PROBL, V289, P289

[19]

RAI AK, 2004, INT PUBLIC GOODS TRA

[20]

Rao M, 2005, J ALZHEIMERS DIS, V8, P75

← 1 2 3 →